SHTDF News Alert Sinopharm Group Co L (SHTDF) 3.7200 10/01/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sinopharm Group Co L (SHTDF) 3.7200 $SHTDF

Global and Chinese Chemical Reagent Industry Report 2014-2017
M2 - Tue Sep 30, 5:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sjcjmv/global_and) has announced the addition of the "Global and Chinese Chemical Reagent Industry Report, 2014-2017" report to their offering. Chemical reagent, purified from industrial chemicals, serves chiefly scientific experiment and detection analysis, and finds massive application in electronic information, medicine, food, aerospace and military industry manufacturing. In 2013, global chemical reagent market was worth about USD 13.6 billion, with market demand concentrated in United States, Europe and Japan. There are a large variety of chemical reagents, totaling above 250,000 around the world. American Sigma-Aldrich is the company that produces the most varieties of chemical reagents, up to approximate 230,000. Global chemical reagent industry characterizes a fairly high concentration, and American Sigma-Aldrich and German Merck Group, as industry leaders, took up a combined 30% or so market share globally in 2013. China chemical reagent industry has developed quickly, achieving a CAGR of 15.9% as concerns market size during 2007-2013, and making up 19.2% of global market size. Chemical reagent can be divided into general reagent and high-purity reagent, with the latter accounting for about 26% of total market size in China in 2013. High-purity chemical reagent is mainly used in semiconductor industry, and is the product that enjoys the fastest growth rate and has the highest technical content and added value. With the rapid development of China's electronic information, biotechnology, national defense, military industry and other industries, the demand for high purity reagent will keep a roughly 15% growth rate over the next couple years. In 2013, there were more than 400 chemical reagent producers with production licenses in China, most of which focused on low-end products, resulting in fierce competition in the low-end market; by contrast, the high-end market is dominated by transnational companies, such as German Merck Group and American Sigma-Aldrich, which held a combined 16.9% market share in China in 2013. In recent years, concentration of China chemical reagent industry has been improving gradually, mainly reflected by rapid development of large chemical reagent companies. Moreover, China-made chemical reagents are advancing from the low-end to the middle and high-end, with some imported products having been substituted with domestic ones. Typical domestic companies include Xilong Chemical Co., Ltd. and Sinopharm Chemical Reagent Co., Ltd., together occupying 13.2% of the Chinese market in 2013. Key Topics Covered: 1. Overview of Chemical Reagent 2. Chemical Reagent Market 3. Chinese Chemical Reagent Market 4. Foreign Companies 5. Chinese Companies 6. Summary and Forecast Companies Mentioned - Anhui Fulltime Specialized Solvent & Reagent - Danaher - Guangdong Guanghua Sci-Tech - Jianghua Microelectronics Materials - Jiangyin Chemical Reagent Factory - Johnson Matthey - Merck Group - Sigma-Aldrich - Sinopharm Group - Suzhou Crystal Clear Chemical - Suzhou JIMCEL Electronic New Material - TCI - Thermo Fisher - Wako - Xilong Chemical For more information visit http://www.researchandmarkets.com/research/sjcjmv/global_and

Sinopharm, Biostar, Lilly Rise on Medical Modernization in China
at The Street - Mon Aug 18, 1:11PM CDT
Pharmaceutical companies are profiting from China’s urban ailments and a growing appetite for western-style medicinal treatments

Provectus Signs Memorandum of Understanding with Sinopharm-China State Institute of Pharmaceutical Industry, and Sinopharm A-THINK Pharmaceutical Co., Ltd.
Business Wire - Mon Aug 18, 8:19AM CDT
Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT) (http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company ("Provectus" , announced today that it entered into a Memorandum of Understanding ("MOU" with Sinopharm-China State Institute of Pharmaceutical Industry ("Sinopharm-CSIPI" , the leader among all pharmaceutical research institutes in China, and Sinopharm A-THINK Pharmaceutical Co., Ltd. ("Sinopharm A-THINK" , the only injectable anti-tumor drug research and development, manufacture and distribution integrated platform within Sinopharm Group.

China to Host World's Largest Integrated Health Industry Event "tHIS" in 2015
Business Wire - Wed Jun 25, 4:00AM CDT
Reed Sinopharm Exhibitions, the leading healthcare event organizer in China, announced Wednesday the launch of The Health Industry Summit (tHIS) in Shanghai. This new event, to be held 15-18 May 2015 at National Exhibition and Conference Center (Shanghai), the world's largest single block exhibition complex, will combine a Summit program of over 100 conferences with a gigantic 260,000 sqm exhibition area through co-locating three of the leading health industry exhibitions, namely CMEF, PHARMCHINA, API CHINA, effectively forming the world's largest integrated health industry event.

Mitsubishi Corporation and MEDIPAL Team Up with Local Partners to Expand Healthcare Business in China
JCN Newswire - Fri Jul 26, 3:06AM CDT
Medipal Holdings Corporation (MEDIPAL) and Mitsubishi Corporation (MC) have each purchased 20 percent of shares in major Chinese pharmaceutical wholesaler, Sinopharm Group Beijing Tianxingpuxin Bio-med Sinopharm Holding Co., Ltd. (Tianxingpuxin) in Beijing.

China Orthopedic Instrument Import and Export TOP50 Report, 2012
M2 - Tue Feb 05, 5:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/k7ddj4/china_orthopedic) has announced the addition of the "China Orthopedic Instrument Import and Export TOP50 Report, 2012" report to their offering. China Orthopedic Instrument Import and Export TOP 50 Report, 2012 covers 5 chapters and 75 charts, the main content of which includes the following: - Chinese macroeconomic development trend and forecast - Chinese medical instrument industry supply and demand, and analysis and forecast of future development trend from the perspectives of people's life and economy - Chinese orthopedic instrument import and export, 2010-2012 - Top 50 Chinese orthopedic instrument enterprises by import and export value, and top 25 importers and exporters - Detailed introduction of top 50 enterprises by import and export value, mainly covering the company profile, website, contact information, financial situation, monthly import and export value in 2012, etc. Key Topics Covered: 1 Macro-economic Environment




Scroll down for more posts ▼

Top 10 Most Recent News Articles

ECW Puts $52 Million Behind Learning Through Crisis

Updated Category News Views 66

A reserve fund for a classroom is not glamorous, but it may be the smartest detail in this whole $52 million commitment. Education Cannot Wait has announced support for more than 300,000 children in Lebanon, Myanmar and South Sudan, where war, flooding and displacement have ripped ordinary schooling apart. The money is meant to restore learning, provide catch-up classes...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 22

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
YYForce Security Win Adds Recurring Singapore Revenue Base

Updated Category News Views 160

A retail-property security mandate rarely makes anyone pound the table, and frankly it should not. Still, YYForce has landed a tangible two-year contract in Singapore worth roughly S$831,120, with subsidiary Uniforce Security Services set to begin work on December 1, 2026. For NASDAQ:YFOR investors, this is the kind of small, operationally real win that deserves a sober...

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 58

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
Niron's $1.8B Alabama Bet Carries Big Magnet Stakes

Updated Category News Views 54

A Huge Factory Claim Needs More Than Applause A magnet company just tossed a very large number onto Alabama's economic-development table. Niron Magnetics says it plans a $1.8 billion investment in the state that would create 700 jobs. That is not pocket change, not a ribbon-cutting trinket, and not the sort of announcement investors should breeze past between earnings...

Continue Reading
Appian Survey Flags AI Aloneware Maintenance Drag Risk

Updated Category News Views 58

A bot can spit out a feature before lunch, then leave a repair bill nobody budgeted for. That is the uncomfortable issue behind Appian's new research on AI-assisted software development: speed is easy to celebrate, while ownership gets shoved into a dark corner until something breaks. Appian said on November 20, 2026, that two-thirds of surveyed AI decision-makers and IT...

Continue Reading
Sogroya Approval Broadens Novo's Pediatric Growth Franchise

Updated Category News Views 75

Seven fewer injections every week is the real headline behind Novo Nordisk's latest FDA clearance, not some flashy efficacy leap. On November 20, 2026, the company said Sogroya, its once-weekly long-acting growth hormone, won approval for children aged 2.5 and older with growth failure associated with Turner syndrome. That matters because treatment can stretch over years,...

Continue Reading
PCS Rental Prep Is About Control Before Distance Hits

Updated Category News Views 82

A vacant house can turn into a long-distance headache with startling speed. For military homeowners preparing for a PCS move, the useful point in Rhonda Leahy's guidance is not glamorous: settle the boring operational stuff before the moving boxes, travel orders, and new-duty-station chaos swallow the calendar. Renting out a former home is not merely collecting enough...

Continue Reading
Mobile Core's Cost Crunch Favors Telecom's Big Three

Updated Category News Views 67

Server bills have finally crashed the party in mobile core, and nobody should pretend that is a minor inconvenience. Dell'Oro Group's 3Q 2026 read is blunt: Mobile Core Network revenue growth was lackluster because 5G spending came in below expectations, while higher server costs pushed operators to reshuffle priorities, postpone projects, and keep 4G core gear alive...

Continue Reading
Why Brief Chiropractic Visits Still Need Clear Expectations

Updated Category News Views 76

A few minutes on the table can sound almost suspiciously brisk when somebody is dealing with a stiff neck, sore back, or nagging joint discomfort. Yet that is the central point in Dr. Craig Peterson's explanation for HelloNation: the adjustment itself may be brief, while the value of a chiropractor visit depends on a focused assessment, appropriate technique, and whether...

Continue Reading

Top 5 Most Recently Viewed Articles

Organon & Co. Class Action Lawsuit: Key Details You Should Know

Updated Category News Views 221

Overview of the Class Action Lawsuit Against Organon & Co. The latest developments in the class action lawsuit regarding Organon & Co. (NYSE: OGN) have attracted attention from investors. The lawsuit is aimed at representing purchasers of Organon's publicly traded securities during a specific time frame. Robbins Geller Rudman & Dowd LLP has taken the lead in filing this...

Continue Reading
JINRO Partners with BTS's V: A Strategic Move

Updated Category News Views 25

What's Brewing Between JINRO and BTS's V? Picture this: you're wandering the aisles of an international market, see a splashy new bottle of soju, and notice V from BTS smiling from the label. That's right, folks, JINRO, the world's reigning soju brand, has just snagged a partnership with BTS's V to serve up a global brand punch. This move isn't just a pretty face on a...

Continue Reading
Latin Metals Unveils Exciting Spin-Out Plan for Copper Assets

Updated Category News Views 172

Latin Metals Moves Forward with Spin-Out of Peruvian Assets Latin Metals Inc. (TSXV: LMS, OTCQB: LMSQF) is charting a new course by announcing its decision to spin-out certain Peruvian exploration projects into a newly founded subsidiary named Latin Explore. This strategic move aims to unlock value for shareholders while maintaining a robust exploration agenda. Overview...

Continue Reading
McCormick's Resilience Shines Amidst Economic Challenges

Updated Category News Views 66

McCormick Challenges and Growth Strategy McCormick & Company, Inc. (NASDAQ: MKC) recently announced its third-quarter earnings, revealing a solid financial performance, even in a tough consumer environment. The company achieved a 1% volume growth in its Consumer segment and steady sales in its Flavor Solutions segment, showcasing a strong market presence despite...

Continue Reading
Goodyear's Financial Performance Amidst Industry Challenges

Updated Category News Views 248

Understanding Goodyear's Recent Earnings Report Goodyear Tire & Rubber Co (NASDAQ: GT) has reported its recent financial results, particularly highlighting the challenges faced during the second quarter of their fiscal year 2025. This period proved to be quite turbulent after the closing bell, reflecting considerable disruptions in their operating environment that...

Continue Reading